Outset Medical Reports Unaudited Fourth Quarter and 2025 Results

About this update from Outset Medical, Inc.

[{"type":"image","alt":"Outset Medical, Inc.","displaySize":"","headline":null,"caption":"Outset Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/dbf72cbabf20edef2d3c5e04f8a2ce35"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/81TozlI2nSbjNuKd34NOOQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/dbf72cbabf20edef2d3c5e04f8a2ce35","width":300,"height":150}},"lazy":false},{"type":"text","content":"Appoints Medical Technology Veteran Karen N. Prange to Board of Directors","length":73,"tagName":"p"},{"type":"text","content":"SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, and named Karen N. Prange to its board of directors.","length":346,"tagName":"p"},{"type":"text","content":"Unaudited Fourth Quarter and 2025 Results","length":41,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue in the fourth quarter totaled approximately $28.9 million, bringing revenue for 2025 to approximately $119.5 million, a 5% increase over $113.7 million in 2024.","length":168,"tagName":"p"}]},{"val":[{"type":"text","content":"Exiting 2025, more than 1,000 sites of care have insourced dialysis with Outset, performing roughly 1 million treatments per year and more than 3 million cumulative treatments on Tablo.","length":185,"tagName":"p"}]},{"val":[{"type":"text","content":"Year-end cash, including restricted cash, cash equivalents and short-term investments, totaled $173 million. Net cash used in operations in 2025 was below $50 million compared to $116 million in 2024. ","length":200,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":553,"olType":false},{"type":"text","content":"“We enter 2026 with a strong backlog, a growing pipeline of new opportunities and a great deal of confidence that the value we deliver for providers and dialysis patients can continue to fuel Outset’s growth for many years to come,” said Leslie Trigg, Chair and Chief Executive Officer. “In 2026, we look forward to building on our innovation track record by deliver...

More updates from Outset Medical, Inc.